This HTML5 document contains 43 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
n15http://linked.opendata.cz/resource/drugbank/drug/DB02587/identifier/pubchem-substance/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB02587/identifier/drugbank/
foafhttp://xmlns.com/foaf/0.1/
n14http://bio2rdf.org/drugbank:
n9http://linked.opendata.cz/resource/drugbank/drug/DB02587/identifier/chemspider/
admshttp://www.w3.org/ns/adms#
n16http://linked.opendata.cz/resource/drugbank/drug/DB02587/identifier/chebi/
n18http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n17http://linked.opendata.cz/resource/drugbank/drug/DB02587/identifier/wikipedia/
n3http://linked.opendata.cz/ontology/drugbank/
n19http://linked.opendata.cz/resource/drugbank/drug/DB02587/identifier/pharmgkb/
n4http://linked.opendata.cz/resource/drugbank/property/
n6http://www.drugs.com/npc/
n8http://linked.opendata.cz/resource/drugbank/drug/DB02587/identifier/pdb/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/resource/drugbank/drug/DB02587/identifier/pubchem-compound/

Statements

Subject Item
n2:DB02587
rdf:type
n3:Drug
n3:description
Potent activator of the adenylate cyclase system and the biosynthesis of cyclic AMP. From the plant Coleus forskohlii. Has antihypertensive, positive ionotropic, platelet aggregation inhibitory, and smooth muscle relaxant activities; also lowers intraocular pressure and promotes release of hormones from the pituitary gland. [PubChem]
n3:group
experimental
owl:sameAs
n14:DB02587 n18:DB02587
dcterms:title
Forskolin
adms:identifier
n8:FOK n9:43607 n10:DB02587 n12:47936 n15:46509044 n16:42471 n17:Forskolin n19:PA146096022
n3:synthesisReference
Emiko Yamasaki, Takaaki Ohkuma, "Lyophilized preparation of 6-(3-dimethylaminopropionyl)forskolin." U.S. Patent US5051132, issued June, 1974.
foaf:page
n6:forskolin.html
n3:IUPAC-Name
n4:271B453B-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4541-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4540-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B453D-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B453E-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B453F-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4539-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B453A-363D-11E5-9242-09173F13E4C5 n4:271B4537-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4538-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4547-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4548-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4542-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4543-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4545-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4544-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4546-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
64657-11-0
n3:Bioavailability
n4:271B454D-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B454F-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4550-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B454C-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B454B-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B454E-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B453C-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4549-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B454A-363D-11E5-9242-09173F13E4C5